What does Nanobac Pharmaceuticals, Incorporated do?

Nanobac Pharmaceuticals, Incorporated (NNBP) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is NNBP's market cap?

Nanobac Pharmaceuticals, Incorporated (NNBP) has a market capitalization of approximately $24,951, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does NNBP pay a dividend?

No — Nanobac Pharmaceuticals, Incorporated (NNBP) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

NNBP

Nanobac Pharmaceuticals, Incorporated

OTC·Biotechnology · Healthcare

$0.00$0.00+0.00%

Market cap$24.95K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−60.00%CAGR −16.75%

Select date range

FromTo

Oct 31, 1994Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

NNBP does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue$17.62K

Net Income−$6.58M

Net Margin−37,319.7%

Operating Cash Flow−$910.89K

Capital Expenditures$1.53K

Free Cash Flow−$912.42K

Return on Equity—

Return on Invested Capital24.9%

Net Debt$4.12M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for NNBP and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how NNBP's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NNBP and 80,000+ other tickers.

About Nanobac Pharmaceuticals, Incorporated

Nanobac Pharmaceuticals, Incorporated is dedicated to advancing human health through the creation and refinement of products and services designed for the identification and management of calcifying nanoparticles (CNPs). The company's offerings include the production and sale of in vitro diagnostic (IVD) kits, which encompass assays, antibodies, and reagents specifically developed for detecting CNPs. Notably, their diagnostic assays include NANO-CAPTURE and NANO-SERO. Furthermore, Nanobac engages in research and clinical studies focused on various urological diseases—such as chronic…

CEO: John Stanton
Sector: Healthcare
Industry: Biotechnology
Exchange: OTC
Employees: 1
Website: www.nanobac.com

Peers

Molecular Pharmacology (USA), Ltd.

Cap

$643.7K

MRPI

Mera Pharmaceuticals, Inc.

Cap

$55.7K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About NNBP

What does Nanobac Pharmaceuticals, Incorporated do?: Nanobac Pharmaceuticals, Incorporated (NNBP) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is NNBP's market cap?: Nanobac Pharmaceuticals, Incorporated (NNBP) has a market capitalization of approximately $24,951, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does NNBP pay a dividend?: No — Nanobac Pharmaceuticals, Incorporated (NNBP) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.